Enliven Therapeutics shares owned by Bellevue Group
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $91M | 2.3M | 39.20 |